4//SEC Filing
Caissa Capital Management ltd. 4
Accession 0001929354-23-000008
CIK 0001534120other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 5:23 PM ET
Size
9.4 KB
Accession
0001929354-23-000008
Insider Transaction Report
Form 4
Caissa Capital Management ltd.
10% Owner
Transactions
- Purchase
Common stock
2023-05-15$2.55/sh+1,715$4,366→ 1,346,700 total(indirect: See Footnote (1)) - Purchase
Common stock
2023-05-16$2.75/sh+379$1,042→ 1,347,079 total(indirect: See Footnote (1)) - Purchase
Common stock
2023-05-12$2.45/sh+2,285$5,598→ 1,344,985 total(indirect: See Footnote (1))
Holdings
- 182,300
Common stock
Footnotes (3)
- [F1]Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.45 to $2.79, inclusive.
- [F3]These shares are directly owned by Mr. Golestaneh in his personal capacity.
Documents
Issuer
Avalo Therapeutics, Inc.
CIK 0001534120
Entity typeother
IncorporatedVirgin Islands, British
Related Parties
1- filerCIK 0001929354
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 5:23 PM ET
- Size
- 9.4 KB